CYBERDYNE Inc. (JP:7779)
:7779
Want to see JP:7779 full AI Analyst Report?
7779 Stock Chart & Stats
¥216.00
-¥5.00(-2.72%)
At close: 4:00 PM EST
¥216.00
-¥5.00(-2.72%)
Day’s Range― - ―
52-Week Range¥164.00 - ¥420.00
Previous CloseN/A
Volume1.10M
Average Volume (3M)724.97K
Market Cap
¥63.76B
Enterprise Value¥32.07B
Total Cash (Recent Filing)¥9.20B
Total Debt (Recent Filing)¥434.00M
Price to Earnings (P/E)87.8
Beta0.85
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.57
Shares Outstanding137,445,820
10 Day Avg. Volume764,380
30 Day Avg. Volume724,970
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)0.93
Price to Sales (P/S)8.43
P/FCF Ratio-50.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥410.00Price Target Upside89.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.03
Revenue Forecast (FY)¥4.96B
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetVery low debt-to-equity (~1–2%) and a stable equity base provide durable financial flexibility for CYBERDYNE. This reduces refinancing risk, supports continued R&D and commercialization of HAL, and gives runway to scale deployments or pursue partnerships without immediate funding pressure.
Healthy Gross Margins And Improving LossesSustained gross margins (~53–69%) indicate solid unit economics for HAL devices and services. Coupled with a materially narrowed loss profile in the TTM, this suggests operating leverage potential: if revenue growth resumes, profitability can improve without proportional cost increases.
Proprietary HAL Platform And Service ModelCYBERDYNE's HAL exoskeleton and related cybernics services create a specialized, hard-to-replicate offering in medical rehabilitation. The combination of device sales plus training, maintenance and deployment services supports recurring revenue and creates barriers to entry—structural advantages in aging healthcare markets.
Bears Say
Persistent Net LossesNet losses across reported periods indicate CYBERDYNE has not yet achieved sustainable profitability. Continued negative earnings limit internal reinvestment capacity, raise the probability of future capital raises, and lengthen the timeline to generate investor returns from operations alone.
Consistent Negative Operating And Free Cash FlowOngoing negative operating and free cash flows mean the business is not self-funding its growth. Even with reduced TTM cash burn, persistent cash deficits constrain spending on commercialization, require external financing for scale-up, and increase execution risk over the medium term.
Recent Revenue Momentum SoftenedAfter multi-year growth, TTM revenue decline and negative reported revenue growth suggest weakening demand or slower adoption. This slows the path to leverage fixed costs, delays breakeven, and heightens reliance on improved sales execution or new structural partnerships to restore growth.
CYBERDYNE News
7779 FAQ
What was CYBERDYNE Inc.’s price range in the past 12 months?
CYBERDYNE Inc. lowest stock price was ¥164.00 and its highest was ¥420.00 in the past 12 months.
What is CYBERDYNE Inc.’s market cap?
CYBERDYNE Inc.’s market cap is ¥63.76B.
When is CYBERDYNE Inc.’s upcoming earnings report date?
CYBERDYNE Inc.’s upcoming earnings report date is May 14, 2026 which is in 15 days.
How were CYBERDYNE Inc.’s earnings last quarter?
CYBERDYNE Inc. released its earnings results on Feb 12, 2026. The company reported ¥0.57 earnings per share for the quarter, beating the consensus estimate of N/A by ¥0.57.
Is CYBERDYNE Inc. overvalued?
According to Wall Street analysts CYBERDYNE Inc.’s price is currently Undervalued.
Does CYBERDYNE Inc. pay dividends?
CYBERDYNE Inc. does not currently pay dividends.
What is CYBERDYNE Inc.’s EPS estimate?
CYBERDYNE Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CYBERDYNE Inc. have?
CYBERDYNE Inc. has 137,445,820 shares outstanding.
What happened to CYBERDYNE Inc.’s price movement after its last earnings report?
CYBERDYNE Inc. reported an EPS of ¥0.57 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 13.074%.
Which hedge fund is a major shareholder of CYBERDYNE Inc.?
Currently, no hedge funds are holding shares in JP:7779
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CYBERDYNE Inc.
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.
7779 Stock 12 Month Forecast
Average Price Target
¥410.00
▲(89.81% Upside)
Technical Analysis
PHC Holdings Corp.
―
Create Medic Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Koken Ltd.
―
Options Prices
Currently, No data available
---